Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Celsius Holdings Reports Impressive Financial Results for Q4 FY2023

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Beverages Industry Markets and money (1)
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Celsius Holdings has just released their impressive financial results for Q4 FY2023, showing significant growth in various areas. Let’s take a closer look at some of the key highlights from their recent reports:

Revenue Surge: Celsius witnessed an outstanding 95.2% increase in revenue compared to the previous year, hitting $347.4 million, surpassing analyst predictions.

Profit Boost: The company achieved a GAAP profit of $0.17 per share, marking a substantial improvement from the previous year.

Market Reaction: Despite the positive results, Celsius’s stock faced a slight 1.9% decline post-report, trading at $66.42 per share.

Expectations Met: Analysts had projected a revenue growth of 86.2% year-on-year to $331.5 million for this quarter, with adjusted earnings expected at $0.18 per share.

Investor Buzz: Investors have been closely monitoring Celsius, with high hopes fueled by its past performance and strategic partnerships, including those with companies like PepsiCo.

Overall, Celsius Holdings continues to show robust growth and a strong presence in the market, focusing on expanding its product offerings globally and solidifying its position as a leading player in the energy drink industry.

Celsius Holdings Inc. (CELH) Stock Price Drops Slightly on February 29, 2024 – Still Trading Strong Near 52-Week High

On February 29, 2024, Celsius Holdings Inc. (CELH) experienced a slight drop in its stock price. The stock opened at $63.81, which was $3.96 lower than its previous close. Throughout the trading day, CELH shares decreased by $1.74, representing a 2.57% drop in value.

Despite this decrease, CELH is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well overall in the long term. Investors may view this as a positive sign of the company’s stability and growth potential.

Celsius Holdings Inc. Sees 107.97% Increase in Total Revenue in 2024

On February 29, 2024, Celsius Holdings Inc. (CELH) saw a significant increase in its total revenue compared to the previous year and the last quarter. The company reported a total revenue of $653.60 million for the past year, which marks a 107.97% increase from the previous year. In the third quarter alone, CELH reported a total revenue of $384.76 million, showing an 18.07% increase from the previous quarter.

Despite the positive revenue growth, CELH reported a net income of -$187.28 million for the past year. However, in the third quarter, the company reported a net income of $83.95 million.

In terms of earnings per share (EPS), CELH reported a negative EPS of -$0.88 for the past year. In the third quarter, the company reported a positive EPS of $0.30.

Overall, despite the challenges faced by CELH in terms of net income and EPS, the significant increase in total revenue is a positive sign for the company’s performance. Investors will be closely watching CELH stock on February 29, 2024, to see how the market reacts to these financial results.

Tags: CELH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Tech-banking-finance

Barclays Analyst Remains Bullish on Baidu with Adjusted Price Targets

Technology Cloud computing Trading online

Navigating Tapestry Analyst Insights and Projections

Tegna Reports Lower Than Expected Quarterly Financial Results

Recommended

Camping World Stock

Can Camping World Maintain Its Dividend Amid Market Pressures?

5 months ago
Trinity Biotech Stock

Trinity Biotech Faces Critical Nasdaq Compliance Deadline

5 months ago
DVY stock news

Amarin Strengthens Position and Maximizes Shareholder Value Through Share Repurchase Agreement with Cantor Fitzgerald

2 years ago
ASTeMobile Stock

ASTeMobile Shares Face Mounting Pressure as Investor Confidence Wanes

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Trending

Cassava Sciences Stock
Analysis

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

by Jackson Burston
February 8, 2026
0

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed...

DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays
  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com